Qiagen Inks Agreements with Mount Sinai, CHOP Around Ingenuity Variant Analysis | GenomeWeb

Qiagen said this week that the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai School of Medicine has selected its Ingenuity Variant Analysis software solution for translational research applications around characterizing and identifying rare diseases.

In addition, the software will also be used for training purposes. Research scientists and medical students at the institute will also use Variant Analysis to analyze data from their own genomes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.